Halozyme Reports Fourth Quarter And Full-Year 2018 Results
Go back to Halozyme Reports Fourth Quarter And Full-Year 2018 Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 68.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.99 | 52 Week High | $18.39 | |||
| Open | $68.99 | 52 Week Low | $6.96 | |||
| Day High | $68.99 | P/E | N/A | |||
| Day Low | $68.99 | EPS | $-0.58 | |||
| Volume | 41 | |||||
